Details for Patent: 8,461,330
✉ Email this page to a colleague
Which drugs does patent 8,461,330 protect, and when does it expire?
Patent 8,461,330 protects TABRECTA and is included in one NDA.
This patent has seventy-eight patent family members in thirty-six countries.
Summary for Patent: 8,461,330
| Title: | Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| Abstract: | The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways. |
| Inventor(s): | Zhuo; Jincong (Boothwyn, PA), Xu; Meizhong (Hockessin, DE), He; Chunhong (Boothwyn, PA), Zhang; Colin (Ambler, PA), Qian; Ding-Quan (Newark, DE), Burns; David M. (Philadelphia, PA), Li; Yun-Long (Chadds Ford, PA), Metcalf; Brian (Moraga, CA), Yao; Wenqing (Kennett Square, PA) |
| Assignee: | Incyte Corporation (Wilmington, DE) |
| Application Number: | 12/813,148 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 8,461,330
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Pharm | TABRECTA | capmatinib hydrochloride | TABLET;ORAL | 213591-001 | May 6, 2020 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| Novartis Pharm | TABRECTA | capmatinib hydrochloride | TABLET;ORAL | 213591-002 | May 6, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,461,330
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 066142 | ⤷ Try a Trial | |||
| Australia | 2007323725 | ⤷ Try a Trial | |||
| Brazil | PI0719333 | ⤷ Try a Trial | |||
| Canada | 2669991 | ⤷ Try a Trial | |||
| Chile | 2007003341 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
